Ignite Creation Date:
2024-05-06 @ 4:23 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04977453
Status:
RECRUITING
Last Update Posted:
2024-02-22
First Post:
2021-07-09
Brief Title:
GI-101 As a Single Agent or in Combination with Pembrolizumab Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
Sponsor:
GI Innovation Inc
Organization:
GI Innovation Inc
Organization Data
Organization:
GI Innovation Inc
Class:
INDUSTRY
Study ID:
GII-101-P101 MK-3475-B59
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GI Innovation Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |